This topic contains a solution. Click here to go to the answer

Author Question: The use of hearings and reports for program evaluation has what drawback? a. Testimonies and ... (Read 74 times)

james

  • Hero Member
  • *****
  • Posts: 573
The use of hearings and reports for program evaluation has what drawback?
 
  a. Testimonies and reports are generally provided by those with little direct knowledge of programs.
  b. This kind of information is generally biased against programs.
  c. A high level of deception has been found in these hearings and reports.
  d. Those giving testimony and providing reports administer the programs being evaluated.

Question 2

Policy evaluation should consider
 
  a. direct impacts on target groups only.
  b. impacts on both target and nontarget groups.
  c. tangible impacts only, on both target and nontarget groups. d. symbolic impacts only on target groups.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

braelync

  • Sr. Member
  • ****
  • Posts: 350
Answer to Question 1

d

Answer to Question 2

b




james

  • Member
  • Posts: 573
Reply 2 on: Aug 4, 2018
Gracias!


Dominic

  • Member
  • Posts: 328
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

One way to reduce acid reflux is to lose two or three pounds. Most people lose weight in the belly area first when they increase exercise, meaning that heartburn can be reduced quickly by this method.

Did you know?

About 80% of major fungal systemic infections are due to Candida albicans. Another form, Candida peritonitis, occurs most often in postoperative patients. A rare disease, Candida meningitis, may follow leukemia, kidney transplant, other immunosuppressed factors, or when suffering from Candida septicemia.

Did you know?

Medication errors are three times higher among children and infants than with adults.

Did you know?

There are 60,000 miles of blood vessels in every adult human.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library